Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 Abril 2022 News Human Corporate EMA business hours over Easter holiday 12 Abril 2022 News Human Corporate COVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 Abril 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 Abril 2022 News Human COVID-19 Vaccines Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 Abril 2022 News Corporate Fees EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 Marzo 2022 News Human Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 Marzo 2022 News Human Corporate Clinical trials EU recommendations for 2022-2023 seasonal flu vaccine composition 29 Marzo 2022 News Human Vaccines EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V) 29 Marzo 2022 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022 25 Marzo 2022 News Human COVID-19 Medicines 1 … 43 44 45 46 47 Page 47 of 380 48 49 50 51 … 380
EMA and the EUnetHTA 21 consortium set priorities for their collaboration 12 Abril 2022 News Human Corporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022 8 Abril 2022 News Human COVID-19 Pharmacovigilance Referrals Vaccines
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines 6 Abril 2022 News Human COVID-19 Vaccines
Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 Abril 2022 News Corporate Fees
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 Marzo 2022 News Human
Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 Marzo 2022 News Human Corporate Clinical trials
EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V) 29 Marzo 2022 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022 25 Marzo 2022 News Human COVID-19 Medicines